nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns
|
Goldman, Stephen A. |
|
2016 |
39 |
10 |
p. 895-901 |
artikel |
2 |
Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions
|
Slim, Mahmoud |
|
2016 |
39 |
10 |
p. 925-943 |
artikel |
3 |
Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study
|
Hoppe, Christian |
|
2016 |
39 |
10 |
p. 977-988 |
artikel |
4 |
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects
|
Convertino, Irma |
|
2016 |
39 |
10 |
p. 903-924 |
artikel |
5 |
Neuropsychiatric Effects of HIV Antiviral Medications
|
Treisman, Glenn J. |
|
2016 |
39 |
10 |
p. 945-957 |
artikel |
6 |
Pacific Island Pharmacovigilance: The Need for a Different Approach
|
McEwen, John |
|
2016 |
39 |
10 |
p. 891-894 |
artikel |
7 |
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
|
Härmark, Linda |
|
2016 |
39 |
10 |
p. 883-890 |
artikel |
8 |
Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale
|
Rachlis, Beth |
|
2016 |
39 |
10 |
p. 959-976 |
artikel |
9 |
16th ISoP Annual Meeting ‘‘Pharmacovigilance for Safer Tomorrow’’ Agra, India 16–19 October, 2016
|
|
|
2016 |
39 |
10 |
p. 989-1042 |
artikel |